Your browser doesn't support javascript.
loading
Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.
Suzuki, Rikio; Kitamura, Yuka; Ogiya, Daisuke; Ogawa, Yoshiaki; Kawada, Hiroshi; Ando, Kiyoshi.
Afiliação
  • Suzuki R; Department of Hematology/Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. Rikio_Suzuki@tsc.u-tokai.ac.jp.
  • Kitamura Y; Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Ogiya D; Department of Hematology/Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
  • Ogawa Y; Department of Hematology/Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
  • Kawada H; Department of Hematology/Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
  • Ando K; Department of Hematology/Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Int J Hematol ; 115(2): 233-243, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34741230

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos Heterocíclicos com 3 Anéis / Hidrazinas / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos Heterocíclicos com 3 Anéis / Hidrazinas / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article